Analysts Set UnitedHealth Group Incorporated (NYSE:UNH) PT at $630.35

UnitedHealth Group Incorporated (NYSE:UNH) has received a consensus recommendation of “Buy” from the twenty-two analysts that are covering the firm, Marketbeat reports. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $632.85.

A number of research firms recently commented on UNH. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. KeyCorp reissued an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Truist Financial lifted their target price on UnitedHealth Group from $610.00 to $660.00 and gave the company a “buy” rating in a research report on Friday, April 11th.

UnitedHealth Group Stock Down 22.0 %

UNH opened at $456.10 on Friday. UnitedHealth Group has a fifty-two week low of $438.50 and a fifty-two week high of $630.73. The company has a market capitalization of $417.20 billion, a P/E ratio of 29.43, a P/E/G ratio of 1.37 and a beta of 0.61. The stock has a fifty day moving average of $514.51 and a 200-day moving average of $541.53. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the business posted $6.91 earnings per share. On average, equities analysts expect that UnitedHealth Group will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Institutional Trading of UnitedHealth Group

A number of institutional investors have recently bought and sold shares of the company. Chicago Capital LLC grew its stake in UnitedHealth Group by 3.4% during the first quarter. Chicago Capital LLC now owns 1,027 shares of the healthcare conglomerate’s stock worth $538,000 after purchasing an additional 34 shares during the period. Consilium Wealth Advisory LLC lifted its position in shares of UnitedHealth Group by 5.8% during the 1st quarter. Consilium Wealth Advisory LLC now owns 5,177 shares of the healthcare conglomerate’s stock valued at $2,712,000 after acquiring an additional 282 shares during the period. Vista Investment Partners LLC grew its holdings in UnitedHealth Group by 54.7% in the first quarter. Vista Investment Partners LLC now owns 1,262 shares of the healthcare conglomerate’s stock worth $661,000 after purchasing an additional 446 shares during the period. Inscription Capital LLC bought a new position in shares of UnitedHealth Group during the 1st quarter worth about $3,011,000. Finally, JLB & Associates Inc. increased its position in UnitedHealth Group by 0.7% in the 1st quarter. JLB & Associates Inc. now owns 37,251 shares of the healthcare conglomerate’s stock valued at $19,510,000 after buying an additional 243 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.